1-3 of 3
Balkis Meddeb, MD
Close
Sort by
Journal Articles

Human Platelet Alloantigens (HPA)1, HPA2 and HPA3 SNPs in Tunisian Sickle Cell Disease Patients

Adel Driss, PhD, MSc, BSc, Karima Kacem, MD, Nana Wilson, MPH, Jacqueline Hibbert, PhD, Tom Adamkiewicz, MD, MSCR, FRCP(C), Beatrice E Gee, MD, Balkis Meddeb, MD, Jonathan K Stiles, PhD
Journal: Blood
Blood (2011) 118 (21): 4852.
https://doi.org/10.1182/blood.V118.21.4852.4852
Published: 2011
Journal Articles

Results with ATRA and Anthracycline Based Chemotherapy (CT) in Acute Promyelocytic Leukemia (APL) in a Developing Country. Should Dose Intensity Be Reduced to Obtain Acceptable Results?

Ramzi Jeddi, Hèla Ghédira, Hèla Stambouli, Ramzi Ben amor, Karima Kacem, MD, Yosr Ben Abdennebi, Mohamed Zarrouk, Hend Ben Neji, Raihane ben Lakhal, Lamia Aissaoui, Samia Menif, Emna Gouider, Hèla Ben Abid, Zaher Ben Hadjali, Pierre Fenaux, MD, PhD, Balkis Meddeb, MD
Journal: Blood
Blood (2011) 118 (21): 4271.
https://doi.org/10.1182/blood.V118.21.4271.4271
Published: 2011
Journal Articles

Long-Term Safety and Efficacy of Oral Eltrombopag for the Treatment of Subjects with Idiopathic Thrombocytopenic Purpura (ITP): Preliminary Data from the EXTEND Study.

James B. Bussel, MD, Gregory Cheng, MD, Lidia Kovaleva, MD, Mansoor N. Saleh, MD, Balkis Meddeb, MD, Bhabita Mayer, PhD, J. Lee Fraser, PhD, Manuel Aivado, MD
Journal: Blood
Blood (2007) 110 (11): 566.
https://doi.org/10.1182/blood.V110.11.566.566
Published: 2007